• NASDAQ

Biostem Technologies Inc

BSEM医療関連
2.41
前日比
-0.07(-2.83%)
  • 15分ディレイ株価

Biostem Technologies Incの企業情報(従業員数・代表者名など)

最終更新

特色

BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The Company's products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AMERICAN AMNION. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. It also owns BioTissue's surgical and wound care business, including the Neox and Clarix product lines.

英文社名Biostem Technologies Inc
本社所在地2836 Center Port Cir POMPANO BEACH, FL 33064 USA
電話番号954 380-8342
設立年月2009年2月
代表者名Jason Matuszewski
業種名医療関連(Health Care)
市場名---
従業員数---
ウェブサイトhttps://www.biostemtechnologies.com/
【PR】堅調な伸びを続ける「米国株」について学ぼう!高配当などおすすめ銘柄や選び方は? - マネックス証券 - Yahoo!ファイナンス

米国株ランキング

マーケット指標